IL240289A0 - c19-modified triterpenoids with HIV maturation inhibitory activity - Google Patents
c19-modified triterpenoids with HIV maturation inhibitory activityInfo
- Publication number
- IL240289A0 IL240289A0 IL240289A IL24028915A IL240289A0 IL 240289 A0 IL240289 A0 IL 240289A0 IL 240289 A IL240289 A IL 240289A IL 24028915 A IL24028915 A IL 24028915A IL 240289 A0 IL240289 A0 IL 240289A0
- Authority
- IL
- Israel
- Prior art keywords
- inhibitory activity
- hiv maturation
- maturation inhibitory
- modified triterpenoids
- triterpenoids
- Prior art date
Links
- 230000002401 inhibitory effect Effects 0.000 title 1
- 230000035800 maturation Effects 0.000 title 1
- 150000003648 triterpenes Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361761403P | 2013-02-06 | 2013-02-06 | |
| PCT/US2014/014647 WO2014123889A1 (en) | 2013-02-06 | 2014-02-04 | C-19 modified triterpenoids with hiv maturation inhibitory activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL240289A0 true IL240289A0 (en) | 2015-09-24 |
Family
ID=50150818
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL240289A IL240289A0 (en) | 2013-02-06 | 2015-08-02 | c19-modified triterpenoids with HIV maturation inhibitory activity |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20140221361A1 (enExample) |
| EP (1) | EP2953960A1 (enExample) |
| JP (1) | JP6186010B2 (enExample) |
| KR (1) | KR20150115881A (enExample) |
| CN (1) | CN105121454A (enExample) |
| AR (1) | AR094684A1 (enExample) |
| AU (1) | AU2014215468B2 (enExample) |
| BR (1) | BR112015018491A2 (enExample) |
| CA (1) | CA2900124A1 (enExample) |
| EA (1) | EA027371B1 (enExample) |
| IL (1) | IL240289A0 (enExample) |
| MX (1) | MX2015010003A (enExample) |
| SG (1) | SG11201505639SA (enExample) |
| TW (1) | TW201443073A (enExample) |
| WO (1) | WO2014123889A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8906889B2 (en) * | 2012-02-15 | 2014-12-09 | Bristol-Myers Squibb Company | C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity |
| KR20180028535A (ko) | 2015-07-28 | 2018-03-16 | 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 | Hiv 감염을 예방하거나 치료하기 위한 베투인 유도체 |
| JP2018521093A (ja) | 2015-07-28 | 2018-08-02 | グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ （Ｎｏ．２） Ｌｉｍｉｔｅｄ | Ｈｉｖ感染を予防または治療するためのベツイン誘導体 |
| WO2017025901A1 (en) * | 2015-08-11 | 2017-02-16 | Hetero Research Foundation | Novel c28-analogues with c3-modifications of triterpene derivatives as hiv inhibitors |
| KR20180054826A (ko) | 2015-09-24 | 2018-05-24 | 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 | Hiv 성숙 억제 활성을 갖는 화합물 |
| AU2017208874A1 (en) | 2016-01-20 | 2018-08-02 | Glaxosmithkline Intellectual Property (No.2) Limited | Amine derivatives of lupanes with HIV maturation inhibitory activity |
| AR107512A1 (es) * | 2016-02-04 | 2018-05-09 | VIIV HEALTHCARE UK Nº 5 LTD | Triterpenoides modificados en c-3 y c-17 como inhibidores del vih-1 |
| WO2017149518A1 (en) * | 2016-03-04 | 2017-09-08 | Hetero Labs Limited | C-3 novel triterpene with c-17 amine derivatives as hiv inhibitors |
| US10493070B2 (en) | 2016-06-30 | 2019-12-03 | Viiv Healthcare Uk (No. 5) Limited | Azadecalin derivatives as inhibitors of human immunodeficiency virus replication |
| WO2018044852A1 (en) * | 2016-08-31 | 2018-03-08 | Viiv Healthcare Company | Combinations and uses and treatments thereof |
| WO2018044853A1 (en) * | 2016-08-31 | 2018-03-08 | Viiv Healthcare Conpany | Combinations and uses and treatments thereof |
| US20210347813A1 (en) | 2018-04-24 | 2021-11-11 | Viiv Healthcare Uk (No. 5) Limited | Compounds with hiv maturation inhibitory activity |
| CA3101643C (en) * | 2018-06-29 | 2023-02-21 | Dfh Therapeutics | Triterpene amine derivatives |
| MY201070A (en) | 2019-02-11 | 2024-02-01 | Hetero Labs Ltd | Novel triterpene derivatives as hiv inhibitors |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2694048B2 (ja) * | 1991-05-09 | 1997-12-24 | 日立建機株式会社 | 建設機械の油圧駆動装置 |
| US5413999A (en) | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
| FR2683531B1 (fr) * | 1991-11-13 | 1993-12-31 | Rhone Poulenc Rorer Sa | Nouveaux derives du lupane, leur preparation et les compositions pharmaceutiques qui les contiennent. |
| US5679828A (en) | 1995-06-05 | 1997-10-21 | Biotech Research Labs, Inc. | Betulinic acid and dihydrobetulinic acid derivatives and uses therefor |
| US20020137755A1 (en) | 2000-12-04 | 2002-09-26 | Bilodeau Mark T. | Tyrosine kinase inhibitors |
| US20040110785A1 (en) | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| US7365221B2 (en) | 2002-09-26 | 2008-04-29 | Panacos Pharmaceuticals, Inc. | Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| US7745625B2 (en) | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
| JP2007529544A (ja) | 2004-03-17 | 2007-10-25 | パナコス ファーマシューティカルズ， インコーポレイテッド | ３−ｏ−（３’，３’−ジメチルスクシニル）ベツリン酸の製薬的な塩 |
| TW200628161A (en) | 2004-11-12 | 2006-08-16 | Panacos Pharmaceuticals Inc | Novel betulin derivatives, preparation thereof and use thereof |
| US20110144069A1 (en) | 2006-10-16 | 2011-06-16 | Myriad Genetics, Incorporated | Compounds for treating viral infections |
| EP2257567A1 (en) | 2008-02-14 | 2010-12-08 | Virochem Pharma Inc. | Novel 17 beta lupane derivatives |
| US9067966B2 (en) | 2009-07-14 | 2015-06-30 | Hetero Research Foundation, Hetero Drugs Ltd. | Lupeol-type triterpene derivatives as antivirals |
| WO2011153319A1 (en) | 2010-06-04 | 2011-12-08 | Bristol-Myers Squibb Company | C-28 amides of modified c-3 betulinic acid derivatives as hiv maturation inhibitors |
| EP2576585B8 (en) * | 2010-06-04 | 2016-12-21 | VIIV Healthcare UK (No.5) Limited | Modified c-3 betulinic acid derivatives as hiv maturation inhibitors |
| WO2012006190A1 (en) | 2010-06-29 | 2012-01-12 | Huawei Technologies Co., Ltd. | Delegate gateways and proxy for target hosts in large layer 2 and address resolution with duplicated internet protocol addresses |
| EP2670765B1 (en) | 2011-01-31 | 2017-10-18 | Viiv Healthcare Uk (No. 4) Limited | C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity |
| HUE026371T2 (en) * | 2011-01-31 | 2016-05-30 | Bristol Myers Squibb Co | C-28 amines from modified C-3 betulinic acid derivatives as anti-HIV matrices |
| US8906889B2 (en) | 2012-02-15 | 2014-12-09 | Bristol-Myers Squibb Company | C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity |
| WO2013160810A2 (en) * | 2012-04-24 | 2013-10-31 | Hetero Research Foundation | Novel betulinic acid derivatives as hiv inhibitors |
| US8889854B2 (en) | 2012-05-07 | 2014-11-18 | Bristol-Myers Squibb Company | C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity |
-
2014
- 2014-02-04 BR BR112015018491A patent/BR112015018491A2/pt not_active Application Discontinuation
- 2014-02-04 EP EP14705662.6A patent/EP2953960A1/en not_active Withdrawn
- 2014-02-04 CN CN201480019576.0A patent/CN105121454A/zh active Pending
- 2014-02-04 CA CA2900124A patent/CA2900124A1/en not_active Abandoned
- 2014-02-04 KR KR1020157023907A patent/KR20150115881A/ko not_active Withdrawn
- 2014-02-04 WO PCT/US2014/014647 patent/WO2014123889A1/en not_active Ceased
- 2014-02-04 JP JP2015556998A patent/JP6186010B2/ja not_active Expired - Fee Related
- 2014-02-04 SG SG11201505639SA patent/SG11201505639SA/en unknown
- 2014-02-04 EA EA201591406A patent/EA027371B1/ru not_active IP Right Cessation
- 2014-02-04 MX MX2015010003A patent/MX2015010003A/es unknown
- 2014-02-04 AU AU2014215468A patent/AU2014215468B2/en not_active Ceased
- 2014-02-04 US US14/172,389 patent/US20140221361A1/en not_active Abandoned
- 2014-02-05 TW TW103103839A patent/TW201443073A/zh unknown
- 2014-02-06 AR ARP140100400A patent/AR094684A1/es unknown
-
2015
- 2015-08-02 IL IL240289A patent/IL240289A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6186010B2 (ja) | 2017-08-23 |
| SG11201505639SA (en) | 2015-08-28 |
| AU2014215468A1 (en) | 2015-09-24 |
| JP2016507558A (ja) | 2016-03-10 |
| EP2953960A1 (en) | 2015-12-16 |
| EA027371B1 (ru) | 2017-07-31 |
| CN105121454A (zh) | 2015-12-02 |
| KR20150115881A (ko) | 2015-10-14 |
| WO2014123889A1 (en) | 2014-08-14 |
| AU2014215468B2 (en) | 2017-05-18 |
| AR094684A1 (es) | 2015-08-19 |
| US20140221361A1 (en) | 2014-08-07 |
| TW201443073A (zh) | 2014-11-16 |
| CA2900124A1 (en) | 2014-08-14 |
| BR112015018491A2 (pt) | 2017-07-18 |
| EA201591406A1 (ru) | 2015-12-30 |
| MX2015010003A (es) | 2015-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL240289A0 (en) | c19-modified triterpenoids with HIV maturation inhibitory activity | |
| IL243445B (en) | Silencer | |
| IL234077A (en) | C3-Cycloalkanyl tritrapenoids with antioxidant activity of HIV | |
| SG11201508538SA (en) | Complex | |
| GB201308131D0 (en) | Ophthalmoscope | |
| ZA201508187B (en) | Catalyst | |
| GB201318846D0 (en) | Photocatalysts | |
| TWM475794U (en) | Stud | |
| EP2951761A4 (en) | GRAPHICS OF ACTIVITIES | |
| AU351108S (en) | Dough hook | |
| AU353247S (en) | Single suite | |
| GB201321922D0 (en) | Constructions | |
| GB201302016D0 (en) | Catalyst | |
| GB2511396B (en) | Pre-turbocharger catalyst | |
| GB201321230D0 (en) | Catalysts | |
| PT2999815T (pt) | Agulha de corrediça | |
| GB2516720B (en) | Attaching arrangement | |
| GB201319677D0 (en) | Cyclopropanation | |
| GB201311130D0 (en) | Greensleeves I | |
| GB201310953D0 (en) | New catalysts | |
| GB201316462D0 (en) | Creating reports | |
| GB201404608D0 (en) | Nickel direct-plating | |
| GB2520507B (en) | Footswitch Assembly | |
| GB201315808D0 (en) | Fastening arrangement | |
| TWM476151U (en) | Dumplings thread machine structure |